We have two marketed products, approved in the U.S. and Europe.

NEXLETOL Logo | NEXLETOL® (bempedoic acid) tablets

NEXLETOL®

Approved in the United States, European Union, U.K. and Switzerland.

Please see full U.S. Prescribing Information for NEXLETOL.

U.S. healthcare professionals, for more information, please visit  NEXLETOLHCP.com.

To learn more about bempedoic acid in Europe, visit our partner Daiichi-Sankyo Europe.

To learn more about the mechanism of action, please visit nexlizethcp.com/mechanism-of-action.

NEXLIZET® (bempedoic acid and ezetimibe) tablets

NEXLIZET®

Approved in the United States, European Union, U.K. and Switzerland.

Please see full U.S. Prescribing Information for NEXLIZET.

U.S. healthcare professionals, or more information, please visit  NEXLIZETHCP.com.

To learn more about the bempedoic acid and ezetimibe combination in Europe, visit our partner Daiichi-Sankyo Europe.

To learn more about the mechanism of action, please visit nexlizethcp.com/mechanism-of-action.